Judith Anne Shizuru, Director at Jasper Therapeutics, Inc. (JSPR), bought 41,000 shares at $2.43 ($100K) on 2025-09-22, disclosed to the SEC on 2025-09-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.